The emergence of levothyroxine as a treatment for hypothyroidism
- PMID: 27981511
- DOI: 10.1007/s12020-016-1199-8
The emergence of levothyroxine as a treatment for hypothyroidism
Abstract
Objective: To describe the historical refinements, understanding of physiology and clinical outcomes observed with thyroid hormone replacement strategies.
Methods: A Medline search was initiated using the search terms, levothyroxine, thyroid hormone history, levothyroxine mono therapy, thyroid hormone replacement, combination LT4 therapy, levothyroxine Bioequivalence. Pertinent articles of interest were identified by title and where available abstract for further review. Additional references were identified in the course of review of the literature identified.
Results: Physicians have intervened in cases of thyroid dysfunction for more than two millennia. Ingestion of animal thyroid derived preparations has been long described but only scientifically documented for the last 130 years. Refinements in hormone preparation, pharmaceutical production and regulation continue to this day. The literature provides documentation of physiologic, pathologic and clinical outcomes which have been reported and continuously updated. Recommendations for effective and safe use of these hormones for reversal of patho-physiology associated with hypothyroidism and the relief of symptoms of hypothyroidism has documented a progressive refinement in our understanding of thyroid hormone use. Studies of thyroid hormone metabolism, action and pharmacokinetics have allowed evermore focused recommendations for use in clinical practice. Levothyroxine mono-therapy has emerged as the therapy of choice of all recent major guidelines.
Conclusions: The evolution of thyroid hormone therapies has been significant over an extended period of time. Thyroid hormone replacement is very useful in the treatment of those with hypothyroidism. All of the most recent guidelines of major endocrine societies recommend levothyroxine mono-therapy for first line use in hypothyroidism.
Keywords: Levothyroxine; Levothyroxine bioequivalence; Levothyroxine mono therapy; Thyroid hormone history; Thyroid hormone replacement.
Similar articles
-
HISTORICAL AND CURRENT PERSPECTIVE IN THE USE OF THYROID EXTRACTS FOR THE TREATMENT OF HYPOTHYROIDISM.Endocr Pract. 2015 Oct;21(10):1161-70. doi: 10.4158/EP14477.RA. Epub 2015 Jun 29. Endocr Pract. 2015. PMID: 26121440 Review.
-
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028. Thyroid. 2014. PMID: 25266247 Free PMC article.
-
New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.AAPS J. 2005 Mar 30;7(1):E54-8. doi: 10.1208/aapsj070107. AAPS J. 2005. PMID: 16146330 Free PMC article.
-
Thyroxine and treatment of hypothyroidism: seven decades of experience.Endocrine. 2019 Oct;66(1):10-17. doi: 10.1007/s12020-019-02006-8. Epub 2019 Jul 18. Endocrine. 2019. PMID: 31321670 Free PMC article. Review.
-
ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.Endocr Pract. 2016 Nov;22(11):1319-1326. doi: 10.4158/EP161308.OR. Epub 2016 Aug 2. Endocr Pract. 2016. PMID: 27482609 Review.
Cited by
-
LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic Review.Int J Mol Sci. 2024 Aug 25;25(17):9218. doi: 10.3390/ijms25179218. Int J Mol Sci. 2024. PMID: 39273168 Free PMC article.
-
Cellular Responses to Extracellular Vesicles as Potential Markers of Colorectal Cancer Progression.Int J Mol Sci. 2023 Nov 25;24(23):16755. doi: 10.3390/ijms242316755. Int J Mol Sci. 2023. PMID: 38069076 Free PMC article.
-
Infantile hypothyroidism and its relationship with delayed tooth eruption: A case report.J Clin Exp Dent. 2022 Dec 1;14(12):e1039-e1043. doi: 10.4317/jced.59587. eCollection 2022 Dec. J Clin Exp Dent. 2022. PMID: 36601243 Free PMC article.
-
An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.Front Endocrinol (Lausanne). 2022 Jun 9;13:859487. doi: 10.3389/fendo.2022.859487. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757415 Free PMC article. Review.
-
Economic Evaluation of a Pharmacist-Led 5-Day Therapeutic Hold of IV Levothyroxine at an Academic Medical Center.Hosp Pharm. 2022 Feb;57(1):20-25. doi: 10.1177/0018578720970457. Epub 2020 Nov 9. Hosp Pharm. 2022. PMID: 35521003 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
